Faktory ovlivňující léčbu a výsledky léčby erlotinibem u nemocných s nemalobuněčným karcinomem plic na Klinice nemocí plicních a tbc FN Brno a LF MU

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Factors influencing course and outcome of treatment with erlotinib in non small cell lung cancer at the Dept. of Pulmonary Dis. abd TB, Masaryk University Faculty of Medicine and Brno University Hospital
Authors

SKŘIČKOVÁ Jana TOMÍŠKOVÁ Marcela VAŠUTOVÁ Irena KAPLANOVÁ Jana BABIČKOVÁ Lenka KADLEC Bohdan NEBESKÝ Tomáš PAVLÍK T.

Year of publication 2009
Type Article in Proceedings
Conference Faktory ovlivňující léčbu a výsledky léčby erlotinibem u nemocných s nemalobuněčným karcinomem plic na Klinice nemocí plicních a tbc FN Brno a LF MU
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords non-small cell lung cancer; erlotinib; outcome of treatment; Dept. of Pulmonary Dis. and TB - Masaryk Uni. Faculty of Medicine
Description Factors are analysed which influence the course and outcome of treatment with erlotinib in non small cell lung cancer patients at the Dept. of Pulmonary Dis. abd TB, Masaryk University Faculty of Medicine and Brno University Hospital
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.